[{"id":"39a9757e-603e-4914-a65d-4fc7cf4c7941","acronym":"","url":"https://clinicaltrials.gov/study/NCT03999697","created_at":"2021-01-18T19:39:33.061Z","updated_at":"2024-07-02T16:36:58.547Z","phase":"Phase 1","brief_title":"A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies","source_id_and_acronym":"NCT03999697","lead_sponsor":"PersonGen BioTherapeutics (Suzhou) Co., Ltd.","biomarkers":" CD22","pipe":"","alterations":" ","tags":["CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD22-targeted CAR-T cell therapy"],"overall_status":"Unknown status","enrollment":" Enrollment 10","initiation":"Initiation: 12/01/2018","start_date":" 12/01/2018","primary_txt":" Primary completion: 12/01/2020","primary_completion_date":" 12/01/2020","study_txt":" Completion: 12/01/2020","study_completion_date":" 12/01/2020","last_update_posted":"2019-06-27"}]